Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers.

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers.
复制标题

DOI:
10.1186/1756-8722-6-19
复制
发表时间:
2013-02-25
影响因子:
28.5
通讯作者:
Yang XF
Yang XF
中科院分区:
医学1区
文献类型:
--
作者:
Li X;Fang P;Mai J;Choi ET;Wang H;Yang XF

文献摘要

参考文献

被引文献

相似文献

细胞中有多种活性氧(ROS)来源。作为ROS产生的主要位点,线粒体引起了相当大的兴趣,因为最近发现线粒体ROS(mtROS)直接刺激促炎细胞因子的产生,并且如恶性肿瘤、自身免疫性疾病和心血管疾病等不同的病理状况都具有增加的mtROS产生超过基础水平的共同表型。关于这一主题的一些优秀的评论已经发表,但不断变化的新发现要求对这一主题进行更及时和全面的审查。因此,我们更新最近的理解线粒体如何产生和调节生产的线粒体ROS和功能的线粒体ROS在生理和病理条件。此外,我们描述了新开发的方法来探测或抑制ROS,并详细比较这些方法。深入了解这一主题以及mtROS靶向药物在研究中的应用对于开发更好的治疗方法以对抗炎症性疾病和炎症性恶性肿瘤具有重要意义。
There are multiple sources of reactive oxygen species (ROS) in the cell. As a major site of ROS production, mitochondria have drawn considerable interest because it was recently discovered that mitochondrial ROS (mtROS) directly stimulate the production of proinflammatory cytokines and pathological conditions as diverse as malignancies, autoimmune diseases, and cardiovascular diseases all share common phenotype of increased mtROS production above basal levels. Several excellent reviews on this topic have been published, but ever-changing new discoveries mandated a more up-to-date and comprehensive review on this topic. Therefore, we update recent understanding of how mitochondria generate and regulate the production of mtROS and the function of mtROS both in physiological and pathological conditions. In addition, we describe newly developed methods to probe or scavenge mtROS and compare these methods in detail. Thorough understanding of this topic and the application of mtROS-targeting drugs in the research is significant towards development of better therapies to combat inflammatory diseases and inflammatory malignancies.
DOI: 10.3390/ijms14022388
发表时间: 2013-01-24
影响因子: 5.6
作者:
Ciccone S;Maiani E;Bellusci G;Diederich M;Gonfloni S
通讯作者: Gonfloni S
DOI: 10.1126/science.1211485
发表时间: 2011-12-02
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Anastasiou D;Poulogiannis G;Asara JM;Boxer MB;Jiang JK;Shen M;Bellinger G;Sasaki AT;Locasale JW;Auld DS;Thomas CJ;Vander Heiden MG;Cantley LC
通讯作者: Cantley LC
DOI: 10.1084/jem.20102049
发表时间: 2011-03-14
期刊: The Journal of experimental medicine
影响因子: --
作者:
Bulua AC;Simon A;Maddipati R;Pelletier M;Park H;Kim KY;Sack MN;Kastner DL;Siegel RM
通讯作者: Siegel RM
DOI: 10.1161/01.hyp.0000182154.61862.52
发表时间: 2005-10-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Arruda, RMP;Peotta, VA;Vasquez, EC
通讯作者: Vasquez, EC
DOI: 10.1038/nature05354
发表时间: 2006-11-16
期刊: NATURE
影响因子: 64.8
作者:
Baur, Joseph A.;Pearson, Kevin J.;Sinclair, David A.
通讯作者: Sinclair, David A.